In a complex regulatory environment, post-market surveillance is a continuous process that demands precision, adaptability ...

Gilead licences Sprint Bioscience’s pre-clinical TREX1 inhibitor programme, gaining a novel immuno-oncology asset targeting ...

Bristol and London, UK, 26 November 2025 - eXmoor Pharma, the integrated cell and gene therapy CDMO with embedded consultancy expertise, and Royal Free London NHS Foundation Trust, through its Cell ...

The Food for the Brain Foundation’s Cognitive Function Test will now be used to assess blood biomarkers being developed in the ‘READ OUT’ trial, a UK-based research project. The project, headed by ...

Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announces that the company will present at the ...

Queen Square Imaging Centre – the world-leading centre treating patients with Essential Tremor and Parkinson's - has launched a brand-new podcast to support patients called Queen Square in ...

Modus Therapeutics Holding AB (“Modus Therapeutics”) hereby publishes an interim report for the third quarter of 2025. The report is available on the company’s website ( and as an attachment to this ...

"We built real medicine while the industry chased loopholes," said Duane Boise, President and CEO of MMJ International ...

Three units for demonstration within Verizon Innovation Labs VANCOUVER, BC / ACCESS Newswire / November 25, 2025 / UniDoc ...

Global Dental Equipment Market OverviewThe global dental equipment market is projected to grow at a rate of 5–6% over the next five years. Factors such as an aging population, particularly in ...

Biosimilar to Prolia® and DEGEVMA® (denosumab) Biosimilar to Xgeva®Following the positive opinions of the Committee for Medicinal Products for Human Use (CHMP), the European Commission has granted ...